Owen Mumford settles with Gainor over lancet dispute:
This article was originally published in Clinica
Owen Mumford USA and Gainor Medical have reached an out of court settlement over their long-running dispute concerning the companies' safety lancets. The patent infringement case initiated by Owen Mumford has been dropped and Gainor will pay a licence fee on each Owen Mumford Carelet lancet sold, including past sales.
You may also be interested in...
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.
In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into the impact on biopharma commercial activities.